ASX-Dividend-Report-Banner

Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Global Times: Over 12,000 artifacts excavated from Sanxingdui Ruins site as latest achievements of civilization-tracing project revealed
PRNews

Global Times: Over 12,000 artifacts excavated from Sanxingdui Ruins site as latest achievements of civilization-tracing project revealed

BEIJING, Dec. 11, 2023 /PRNewswire/ -- Chinese cultural authorities unveiled its latest archaeological achievements of the national project to trace the origins of Chinese civilization in Beijing...

  • December 11, 2023 11:54 PM AEDT
  • Cision
Global Times: Renowned French director Luc Besson brings latest work 'Dogman' to China
PRNews

Global Times: Renowned French director Luc Besson brings latest work 'Dogman' to China

BEIJING, Dec. 11, 2023 /PRNewswire/ -- When Luc Besson's latest film Dogman hits Chinese cinemas, it is expected to further boost the rebounding Chinese box office so far dominated by domestic fi...

  • December 11, 2023 11:41 PM AEDT
  • Cision
U.S. futures muted as attention turns to upcoming Fed meeting
Stock Market

U.S. futures muted as attention turns to upcoming Fed meeting

Investing.com -- U.S. stock futures were muted on Monday, hovering just below the flatline, as investors prepared for the Federal Reserve's final two-day policy meeting this year.

The Evolution of Sustainable Packaging
World News

The Evolution of Sustainable Packaging

Originally published by Food Engineering magazine By Shawn HarrisMeat packaging has undergone a significant evolution over the years, driven by various factors including labor and productivity co...

  • December 11, 2023 11:35 PM AEDT
  • 3BL
Polished Concrete Market Growth, Worldwide Forecast to 2031
World News

Polished Concrete Market Growth, Worldwide Forecast to 2031

Polished Concrete Market Growth Polished concrete market is projected to reach $3.7 billion by 2031, growing at a CAGR of 5.3% from 2022 to 2031 PORTLAND, OREGON, UNITED STATES, December 11, 2023 /EIN...

INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled
PRNews

INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled

XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- On November 27th, Tianma Innovation Conference (TIC) 2023 was held in Xiamen with the theme of INNOVATION TO INSPIRE, A WONDEROUS FUTURE. Seven Innov...

  • December 11, 2023 11:21 PM AEDT
  • Cision
Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
PRNews

Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East

SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ -- Keppel Corporation Limited (Keppel), through its Infrastructure Division, and AM Green, which is wholly owned and controlled by the founders of...

  • December 11, 2023 11:21 PM AEDT
  • Cision
ACAMS Grants 10 CAMS Scholarships in Japan to Bolster Nation's Anti-Money Laundering Expertise
PRNews

ACAMS Grants 10 CAMS Scholarships in Japan to Bolster Nation's Anti-Money Laundering Expertise

Initiative supports Japan's anti-money laundering (AML) and sanctions compliance push WASHINGTON, Dec. 11, 2023 /PRNewswire/ -- ACAMS, a leading international membership organization dedicated...

  • December 11, 2023 11:08 PM AEDT
  • Cision
China Literature to Acquire Tencent Animation and Comics
PRNews

China Literature to Acquire Tencent Animation and Comics

HONG KONG, Dec. 11, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property (&q...

  • December 11, 2023 11:07 PM AEDT
  • Cision
Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial
PRNews

Mabwell Announces the CDE Approval of Novel Nectin-4 Targeting ADC for Phase III Clinical Trial

SHANGHAI, Dec. 11, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its submission to the Center for Drug Evaluation (CDE) o...

  • December 11, 2023 11:00 PM AEDT
  • Cision
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.